MBTPS1 and neoplasm: Indeed, activation of S1P receptors with S1P agonist ceralifimod (ONO-4641) rendered NK cells less effective at subsequent tumor cell-dependent degranulation and killing, suggesting premature activation of NK cells through S1P receptors desensitizes cells to cytotoxic stimuli.